SCHEMBL5378686

SCHEMBL5378686

Cc1ccc(S(=O)(=O)Nc2ccc(-c3nnc(-c4ccc(OC(F)(F)F)cc4)o3)cc2)cc1C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.61
TP53 P04637 1/20 0.52
MAPT P10636 3/20 0.51
LMNA P02545 2/20 0.51
ALDH1A1 P00352 1/20 0.51
HTT P42858 1/20 0.51
IDH1 O75874 2/20 0.48
GSK3B P49841 3/20 0.47
RORC P51449 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
NPY5R Q15761 1/20 0.46
RXRA P19793 1/20 0.46
FFAR4 Q5NUL3 1/20 0.46
PTGDR2 Q9Y5Y4 1/20 0.46
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC10 Q969S8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5320408 0.91 POLB (0.69) POLBTP53MAPTLMNAIDH1
SCHEMBL5371930 0.86 PTPN2 (0.60) MAPTALDH1A1
SCHEMBL5376622 0.84 PABPC1 (0.57) POLBTP53MAPTLMNAALDH1A1
SCHEMBL5368389 0.83 POLB (0.60) POLBTP53MAPTLMNAIDH1
SCHEMBL5376808 0.82 POLB (0.56) POLBTP53MAPTLMNAALDH1A1
SCHEMBL5372119 0.82 POLB (0.62) POLBIDH1SMN1; SMN2HDAC3HDAC4
SCHEMBL5382106 0.80 PTPN2 (0.64) MAPTALDH1A1
SCHEMBL5371846 0.80 POLB (0.53) POLBTP53MAPTLMNAIDH1
SCHEMBL5388043 0.79 POLB (0.59) POLBMAPTLMNAALDH1A1IDH1
SCHEMBL5376936 0.79 POLB (0.52) POLBTP53MAPTLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD POLB 1807/4885TP53 3421/4885MAPT 1786/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD POLB 2006/4885TP53 3528/4885MAPT 1984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.